TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 10 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $454,000 | -23.1% | 29,927 | 0.0% | 0.04% | +48.1% |
| Q4 2019 | $590,000 | -9.1% | 29,927 | -20.7% | 0.03% | -12.9% |
| Q3 2019 | $649,000 | -19.0% | 37,754 | -16.6% | 0.03% | -20.5% |
| Q2 2019 | $801,000 | -16.0% | 45,271 | -3.4% | 0.04% | -20.4% |
| Q1 2019 | $954,000 | +137.3% | 46,845 | +95.8% | 0.05% | +96.0% |
| Q4 2018 | $402,000 | -53.3% | 23,923 | -40.5% | 0.02% | -39.0% |
| Q3 2018 | $861,000 | -14.0% | 40,223 | -15.1% | 0.04% | -16.3% |
| Q2 2018 | $1,001,000 | -33.9% | 47,391 | -24.6% | 0.05% | -31.0% |
| Q1 2018 | $1,514,000 | -40.4% | 62,891 | -29.6% | 0.07% | -16.5% |
| Q4 2017 | $2,539,000 | -0.9% | 89,362 | -3.8% | 0.08% | 0.0% |
| Q3 2017 | $2,563,000 | +8.4% | 92,860 | -0.3% | 0.08% | +3.7% |
| Q2 2017 | $2,365,000 | +2.3% | 93,103 | -5.5% | 0.08% | +9.3% |
| Q1 2017 | $2,311,000 | +14.6% | 98,492 | +1.5% | 0.08% | -1.3% |
| Q4 2016 | $2,017,000 | -19.9% | 97,074 | -8.2% | 0.08% | -14.6% |
| Q3 2016 | $2,517,000 | +19.3% | 105,707 | +8.1% | 0.09% | +9.9% |
| Q2 2016 | $2,109,000 | +2.2% | 97,822 | +8.3% | 0.08% | -1.2% |
| Q1 2016 | $2,063,000 | -2.4% | 90,310 | +7.7% | 0.08% | +2.5% |
| Q4 2015 | $2,113,000 | +18.0% | 83,820 | +2.4% | 0.08% | +8.1% |
| Q3 2015 | $1,790,000 | -1.5% | 81,889 | +8.8% | 0.07% | +2.8% |
| Q2 2015 | $1,818,000 | -9.3% | 75,268 | -6.1% | 0.07% | +4.3% |
| Q1 2015 | $2,005,000 | +18.8% | 80,174 | -1.0% | 0.07% | +19.0% |
| Q4 2014 | $1,688,000 | -4.8% | 80,989 | -0.7% | 0.06% | +9.4% |
| Q3 2014 | $1,773,000 | -9.8% | 81,587 | -3.8% | 0.05% | -11.7% |
| Q2 2014 | $1,966,000 | -6.8% | 84,771 | -4.6% | 0.06% | -9.1% |
| Q1 2014 | $2,110,000 | -7.2% | 88,830 | -10.3% | 0.07% | +4.8% |
| Q4 2013 | $2,274,000 | -26.8% | 99,073 | -24.7% | 0.06% | -18.2% |
| Q3 2013 | $3,106,000 | -12.8% | 131,498 | -16.7% | 0.08% | -7.2% |
| Q2 2013 | $3,561,000 | – | 157,896 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |